Hepatitis B Community Briefing

The World Health Organization published new guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B in March 2024. They recommend simplified global standards of care for testing and treatment of hepatitis B. WHA welcomes the new guidelines which increase the number of people living with hepatitis B who can access treatment from 8-15% to 50%. While the guidelines are targeted at clinicians, national hepatitis programme managers and policy makers, they are also a key advocacy tool for civil society.  

To support advocates, WHA has developed a community briefing summarising the guidelines’ new recommendations and why the implementation of these is important to improve access for hepatitis testing and treatment. Advocates can also use the briefing’s key messages to ensure their country’s national guidelines reflect the new recommendations as a minimum.